EE 001
Alternative Names: EE-001Latest Information Update: 31 Mar 2025
At a glance
- Originator Anhui HygeianCells BioMedical
- Class Heart failure therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase 0 Heart failure
Most Recent Events
- 11 Dec 2024 Anhui HygeianCells BioMedical completes a Phase-0 trial for Heart failure (In volunteers) in China (IV) (NCT06884111)
- 05 Jun 2024 Phase-0 for Heart failure (In volunteers) in China (IV) (NCT06884111)